ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 70 filers reported holding ODONATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $58,000 | -6.5% | 43,752 | -4.4% | 0.00% | 0.0% |
| Q4 2021 | $62,000 | +264.7% | 45,770 | +683.1% | 0.00% | – |
| Q3 2021 | $17,000 | -19.0% | 5,845 | -1.9% | 0.00% | -100.0% |
| Q2 2021 | $21,000 | +23.5% | 5,961 | +21.1% | 0.00% | – |
| Q1 2021 | $17,000 | -89.0% | 4,921 | -39.1% | 0.00% | -100.0% |
| Q4 2020 | $155,000 | -24.4% | 8,078 | -47.0% | 0.01% | +150.0% |
| Q3 2020 | $205,000 | +159.5% | 15,228 | +719.6% | 0.00% | -33.3% |
| Q2 2020 | $79,000 | +102.6% | 1,858 | +30.8% | 0.00% | +50.0% |
| Q1 2020 | $39,000 | -38.1% | 1,420 | -16.6% | 0.00% | -50.0% |
| Q2 2019 | $63,000 | +250.0% | 1,703 | +106.9% | 0.00% | +300.0% |
| Q1 2019 | $18,000 | -75.0% | 823 | -84.0% | 0.00% | -80.0% |
| Q4 2018 | $72,000 | -29.4% | 5,157 | -2.5% | 0.01% | -28.6% |
| Q3 2018 | $102,000 | +183.3% | 5,288 | +222.8% | 0.01% | +250.0% |
| Q2 2018 | $36,000 | -57.6% | 1,638 | -59.2% | 0.00% | -71.4% |
| Q1 2018 | $85,000 | – | 4,013 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |